EP2659272A4 - Biomarqueurs protéiques de cancer du sein récurrent - Google Patents
Biomarqueurs protéiques de cancer du sein récurrentInfo
- Publication number
- EP2659272A4 EP2659272A4 EP11853746.3A EP11853746A EP2659272A4 EP 2659272 A4 EP2659272 A4 EP 2659272A4 EP 11853746 A EP11853746 A EP 11853746A EP 2659272 A4 EP2659272 A4 EP 2659272A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- breast cancer
- protein biomarkers
- recurrent breast
- recurrent
- biomarkers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201061428145P | 2010-12-29 | 2010-12-29 | |
PCT/US2011/067996 WO2012092529A2 (fr) | 2010-12-29 | 2011-12-29 | Biomarqueurs protéiques de cancer du sein récurrent |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2659272A2 EP2659272A2 (fr) | 2013-11-06 |
EP2659272A4 true EP2659272A4 (fr) | 2015-07-22 |
Family
ID=46383871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11853746.3A Withdrawn EP2659272A4 (fr) | 2010-12-29 | 2011-12-29 | Biomarqueurs protéiques de cancer du sein récurrent |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2659272A4 (fr) |
JP (1) | JP2014502729A (fr) |
AU (1) | AU2011351990A1 (fr) |
CA (1) | CA2823334A1 (fr) |
WO (1) | WO2012092529A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013039477A1 (fr) | 2011-09-12 | 2013-03-21 | University Of South Alabama | Procédés non invasifs de détection de molécules cibles |
CA2902841A1 (fr) * | 2013-03-13 | 2014-10-02 | Creatics Llc | Procedes et compositions pour detecter un cancer du pancreas |
CN104277102B (zh) * | 2014-06-27 | 2017-04-12 | 李光辉 | 一种检测乳腺癌标志物Annexin A1抗原表位氨基酸序列及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090136971A1 (en) * | 2005-05-25 | 2009-05-28 | Krizman David B | Multiplex liquid tissue method for increased proteomic coverage from histopathologically processed biological samples, tissues, and cells |
US20090215636A1 (en) * | 2005-05-25 | 2009-08-27 | Krizman David B | Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1668354A2 (fr) * | 2003-09-24 | 2006-06-14 | Oncotherapy Science, Inc. | Methode de diagnostic du cancer du sein |
WO2007048978A2 (fr) * | 2005-10-28 | 2007-05-03 | Biomerieux Sa | Procede de detection du cancer |
US20090263842A1 (en) * | 2006-03-24 | 2009-10-22 | Expression Pathology | Method of assessing the metastatic status of a primary tumor |
US20110028344A1 (en) * | 2008-04-11 | 2011-02-03 | Expression Pathology, Inc. | Biomarkers for endometrial disease |
AU2009270793A1 (en) * | 2008-07-18 | 2010-01-21 | Oragenics, Inc. | Compositions for the detection and treatment of colorectal cancer |
-
2011
- 2011-12-29 EP EP11853746.3A patent/EP2659272A4/fr not_active Withdrawn
- 2011-12-29 AU AU2011351990A patent/AU2011351990A1/en not_active Abandoned
- 2011-12-29 CA CA2823334A patent/CA2823334A1/fr not_active Abandoned
- 2011-12-29 WO PCT/US2011/067996 patent/WO2012092529A2/fr active Application Filing
- 2011-12-29 JP JP2013547688A patent/JP2014502729A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090136971A1 (en) * | 2005-05-25 | 2009-05-28 | Krizman David B | Multiplex liquid tissue method for increased proteomic coverage from histopathologically processed biological samples, tissues, and cells |
US20090215636A1 (en) * | 2005-05-25 | 2009-08-27 | Krizman David B | Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations |
Non-Patent Citations (3)
Title |
---|
BATEMAN N.W. ET AL.: "Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues", J. PROTEOME RES., vol. 10, no. 3, 14 December 2010 (2010-12-14), pages 1323 - 1332, XP055063617 * |
HOOD B.L. ET AL.: "Proteomic analysis of formalin-fixed prostate cancer tissue", MOL. CELL. PROTEOM., vol. 4, no. 11, 1 November 2005 (2005-11-01), pages 1741 - 1753, XP002482477 * |
PRIETO D.A. ET AL.: "Liquid Tissue(TM): proteomic profiling of formalin-fixed tissues", BIOTECHNIQUES, vol. S6, June 2005 (2005-06-01), pages 32 - 35, XP055163898 * |
Also Published As
Publication number | Publication date |
---|---|
CA2823334A1 (fr) | 2012-07-05 |
WO2012092529A2 (fr) | 2012-07-05 |
WO2012092529A3 (fr) | 2012-08-23 |
JP2014502729A (ja) | 2014-02-03 |
AU2011351990A1 (en) | 2013-07-18 |
EP2659272A2 (fr) | 2013-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL290139A (en) | Optimization of multigene analysis of tumor samples | |
EP2625292A4 (fr) | Biomarqueurs de cancer | |
ZA201209390B (en) | Comparison of protein samples | |
PT3023788T (pt) | Composições de neoantigénios específicos de tumor para utilização no tratamento de tumores | |
IL225545A0 (en) | Antibodies specific to cancerous tumors and their uses | |
EP2536854A4 (fr) | Biomarqueurs tumoraux personnalisés | |
GB2513275B (en) | Biomarkers for Breast Cancer Prediction and Diagnosis | |
IL225441A0 (en) | Breast cancer diagnostics | |
EP2542701A4 (fr) | Biomarqueurs d'arthrose | |
EP2698634A4 (fr) | Biomarqueur pour le cancer du sein | |
EP2748608A4 (fr) | Tests du cancer du poumon | |
EP2550533A4 (fr) | Dépistage précoce d'un cancer du sein récurrent par profilage des métabolites | |
EP2707710A4 (fr) | Diagnostic de cancer | |
GB2536374B (en) | Biomarkers useful for detection of types, grades and stages of human breast cancer | |
EP2600896A4 (fr) | Traitement du cancer du sein avec un anticorps anti-il-19 | |
EP2577298A4 (fr) | Diagnostic du cancer | |
GB2510539B (en) | Biomarkers of cancer | |
EP2531616A4 (fr) | Dosage de diagnostic et de pronostic pour le cancer du sein | |
EP2649225A4 (fr) | Biomarqueurs pour la prédiction du cancer du sein | |
EP2659272A4 (fr) | Biomarqueurs protéiques de cancer du sein récurrent | |
EP2771695A4 (fr) | Procédé de détection de cancers du sein | |
EP2501845A4 (fr) | Biomarqueurs de cancer | |
EP2643482A4 (fr) | Détection précoce du cancer du pancréas | |
EP2732287A4 (fr) | Procédés de diagnostic du cancer | |
EP2658992A4 (fr) | Biomarqueurs protéiques du cancer du sein de stade tardif |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130729 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12Q 1/68 20060101ALI20150212BHEP Ipc: G01N 33/574 20060101AFI20150212BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20150623 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12Q 1/68 20060101ALI20150617BHEP Ipc: G01N 33/574 20060101AFI20150617BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160121 |